SCHEMBL9948678

SCHEMBL9948678

Cn1cc(Br)c(CBr)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15884361 0.82
SCHEMBL27994212 0.80
SCHEMBL11907452 0.80
SCHEMBL31710546 0.80
SCHEMBL15884376 0.78 NPC1 (0.33)
SCHEMBL16120379 0.77
SCHEMBL15884736 0.77 ATM (0.33)
SCHEMBL15884297 0.77 SMN1; SMN2 (0.33)
SCHEMBL12775762 0.77 ALDH1A1 (0.33)
SCHEMBL15884857 0.77 ROCK2 (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116874425-A Method for rapidly preparing 4-bromo-3- (bromomethyl) -1-methyl-1H-pyrazole based on microchannel continuous flow technology 都创(上海)医药开发有限公司 2023-10-13 CN claimed
EP-4739694-A2 MACROCYCLIC COMPOUNDS AND USE AS TYK2 INHIBITORS Blossomhill Therapeutics, Inc. (US) 2026-05-13 EP disclosed
WO-2025010294-A2 MACROCYCLIC COMPOUNDS AND USE AS TYK2 INHIBITORS BLOSSOMHILL THERAPEUTICS, INC. (US) 2025-01-09 WO disclosed
CN-116874425-A Method for rapidly preparing 4-bromo-3- (bromomethyl) -1-methyl-1H-pyrazole based on microchannel continuous flow technology 都创(上海)医药开发有限公司 2023-10-13 CN disclosed
CN-116874425-A Method for rapidly preparing 4-bromo-3- (bromomethyl) -1-methyl-1H-pyrazole based on microchannel continuous flow technology 都创(上海)医药开发有限公司 2023-10-13 CN disclosed
CN-116874425-A Method for rapidly preparing 4-bromo-3- (bromomethyl) -1-methyl-1H-pyrazole based on microchannel continuous flow technology 都创(上海)医药开发有限公司 2023-10-13 CN disclosed
EP-2944637-B1 NITROGEN-CONTAINING HETEROCYLIC COMPOUND OR SALT THEREOF FUJIFILM CORP (JP) 2020-02-19 EP disclosed
EP-2944637-B1 NITROGEN-CONTAINING HETEROCYLIC COMPOUND OR SALT THEREOF FUJIFILM CORP (JP) 2020-02-19 EP disclosed
US-9783536-B2 Nitrogen-containing heterocyclic compound or salt thereof FUJIFILM CORPORATION (JP) 2017-10-10 US disclosed
US-9783536-B2 Nitrogen-containing heterocyclic compound or salt thereof FUJIFILM CORPORATION (JP) 2017-10-10 US disclosed
EP-2944637-A1 NITROGEN-CONTAINING HETEROCYLIC COMPOUND OR SALT THEREOF FUJIFILM Corporation (JP) 2015-11-18 EP disclosed
US-20150322063-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUND OR SALT THEREOF FUJIFILM CORPORATION (JP) 2015-11-12 US disclosed
US-20150322063-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUND OR SALT THEREOF FUJIFILM CORPORATION (JP) 2015-11-12 US disclosed
US-20150322063-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUND OR SALT THEREOF FUJIFILM CORPORATION (JP) 2015-11-12 US disclosed
WO-2014109414-A1 NITROGEN-CONTAINING HETEROCYLIC COMPOUND OR SALT THEREOF 富士フイルム株式会社 (JP) 2014-07-17 WO disclosed
WO-2012101487-A1 DI/TRI-AZA-SPIRO-C9-C11ALKANES NOVARTIS AG (CH) 2012-08-02 WO disclosed
WO-2012101487-A1 DI/TRI-AZA-SPIRO-C9-C11ALKANES NOVARTIS AG (CH) 2012-08-02 WO disclosed
US-20120165331-A1 Di/tri-aza-spiro-C9-C11alkanes AURIGENE DISCOVERY TECHNOLOGIES LIMITED (IN) 2012-06-28 US disclosed
US-20120165331-A1 Di/tri-aza-spiro-C9-C11alkanes AURIGENE DISCOVERY TECHNOLOGIES LIMITED (IN) 2012-06-28 US disclosed
US-20120165331-A1 Di/tri-aza-spiro-C9-C11alkanes AURIGENE DISCOVERY TECHNOLOGIES LIMITED (IN) 2012-06-28 US disclosed